A Trial of the Safety and Efficacy of K-604 for the Treatment of Atherosclerosis

NCT00851500 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

210

Enrollment

INDUSTRY

Sponsor class

Conditions

Atherosclerosis

Interventions

DRUG: K-604
OTHER: Placebo

Sponsor

Kowa Research Institute, Inc.